AIH:NSD-Aesthetic Medical International Holdings Group Limited (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 9.07

Change

+0.72 (+8.62)%

Market Cap

USD 0.20B

Volume

0.12M

Average Target Price

USD 13.00 (+43.33%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye and nose surgery, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. It operates 21 medical treatment centers in China, Hong Kong, and Singapore. The company was founded in 1997 and is headquartered in Shenzhen, China.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-03-31 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AMED Amedisys, Inc

+3.59 (+2.00%)

USD5.23B 42.11 31.01
LHCG LHC Group, Inc

+6.34 (+4.74%)

USD3.92B 40.52 25.53
ENSG The Ensign Group, Inc

-0.76 (-1.98%)

USD1.82B 17.16 17.32
HCSG Healthcare Services Group, Inc

+0.93 (+4.05%)

USD1.69B 26.14 17.39
ACHC Acadia Healthcare Company, Inc

-0.09 (-0.49%)

USD1.64B 14.87 9.21
ADUS Addus HomeCare Corporation

-1.41 (-2.04%)

USD1.07B 47.17 20.62
PRSC The Providence Service Corpora..

-0.11 (-0.20%)

USD0.77B 32.90 17.53
AMEH Apollo Medical Holdings, Inc

-0.82 (-5.97%)

USD0.49B 35.23 12.70
PNTG The Pennant Group, Inc

-1.35 (-8.70%)

USD0.43B N/A 32.51
SGRY Surgery Partners, Inc

-0.28 (-4.11%)

USD0.35B 63.00 13.55

ETFs Containing AIH

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 41.28% 100% A+ 96% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 41.28% 100% A+ 96% A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.20B 39% F 50% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio 276.45 6% F 1% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital 6.94% 39% F 63% D
Return on Assets N/A N/A N/A N/A N/A
Debt to Equity Ratio -270.22% 100% A+ 97% A+
Technical Ratios  
Short Ratio 0.36 89% B+ 87% B+
Short Percent N/A N/A N/A N/A N/A
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.